P. Pollanen

A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.

R. Anderson, E. Nieschlag, D. Apter, 2006, Human reproduction.

A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception.

Frederick C W Wu, P. Devroey, I. Huhtaniemi, 2005, The Journal of clinical endocrinology and metabolism.

Communicating polygenic and non-genetic risk for atherosclerotic cardiovascular disease - An observational follow-up study

V. Salomaa, J. Kaprio, A. Palotie, 2020, medRxiv.